Altimmune (NASDAQ:ALT) Releases Quarterly Earnings Results, Beats Estimates By $0.07 EPS
Altimmune (NASDAQ:ALT – Get Rating) posted its quarterly earnings data on Tuesday. The company reported ($0.57) EPS for the quarter, topping the consensus estimate of ($0.64) by $0.07, MarketWatch Earnings reports. Altimmune had a negative net margin of 2,200.61% and a negative return on equity of 36.90%. During the same quarter last year, the firm […]